HIV and AIDS Immunity Drug Makes Medical Advancement
The Food and Drug Administration approved the use of a drug called Maraviroc for treating the HIV virus this year. The drug, also known by the brand name Selzentry, blocks the CCR5 cell receptor the HIV virus uses to invade and infect white blood cells, invariably slowing down a patient’s immunity breakdown. This is the first HIV or AIDS drug to work in this way in early stages of HIV. Because the drug is new, side-effects are still be studied but early usage of Selzentry has been positive.
This is a great breakthrough for AIDS and HIV research. Though AIDS awareness and information is not as prevalent as it was in the 1990s, it remains a major health threat worldwide and still has a long way to go before a cure can be found. Loved ones are lost because of this disease and fighting it is still at the forefront of many scientists in this country.
For more on Selzentry, visit http://www.selzentry.com/.